Swine A/H1N1 influenza vaccine (split virion, inactivated)

Phase 2

Sanofi (SNYNF)

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

10 competitors in Influenza

MRNAmRNA Flu vaccine

BNTXInfluenza and COVID-19 Combination A

Phase 3

SNYA/H1N1 pandemic influenza vaccine (non- adjuvanted)

Phase 3

NVSSurface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008

Phase 2

BNTXInvestigational COVID-19 Vaccine

Phase 2

View Full Landscape

Drug Information

Target Indication

Influenza

Clinical Trial

NCT01089660

Last updated: 3/4/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book

Drug Science

Mechanism of action & safety profile

Developer

SNYNF

Sanofi

Biotechnology•North America•NASDAQ

Related Pipeline

IrbesartanPhase 3

Atrial Fibrillation

Teriflunomide (HMR1726)Phase 3

Multiple Sclerosis

DTaP-IPV-HB-PRP~T vaccinePhase 3

Diphtheria

Insulin glargine/lixisenatide Fixed Ratio CombinationPhase 3

Type 2 Diabetes

teriflunomide HMR1726Phase 3

Multiple Sclerosis

View full pipeline

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts